Stay updated on FF-10101-01 Study in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.

Latest updates to the FF-10101-01 Study in Relapsed AML Clinical Trial page
- Check3 days agoChange DetectedA minor update to the ClinicalTrials.gov page’s revision/version indicator in the footer (from v3.5.2 to v3.5.3).SummaryDifference0.0%

- Check10 days agoChange DetectedAddition: Revision: v3.5.2; Deletion: Revision: v3.5.0.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page displays Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. This seems to be a minor site update and does not modify study information.SummaryDifference0.0%

Stay in the know with updates to FF-10101-01 Study in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.